缺氧诱导因子与肾性贫血(6)
[32] Besarab A，Chernyavskaya E，Motylev I，et al. Roxadustat(FG-4592)：Correction of Anemia in Incident Dialysis Patients [J]. J Am Soc Nephrol，2016，27(4)：1225-1233.
[33] Hara K，Takahashi N，Wakamatsu A，et al. Pharmacokinetics，pharmacodynamics and safety of single，oral doses of GSK1278863，a novel HIF-prolyl hydroxylase inhibitor，in healthy Japanese and Caucasian subjects [J]. Drug Metab Pharmacokinet，2015，30(6)：410-418.
[34] Brigandi RA，Johnson B，Oei C，et al. A Novel Hypoxia-Inducible Factor-Prolyl Hydroxylase Inhibitor(GSK12 78863)for Anemia in CKD：A 28-Day，Phase 2A Randomized Trial [J]. Am J Kidney Dis，2016，67(6)：861-871.
[35] Flamme I，Oehme F，Ellinghaus P，et al. Mimicking hypoxia to treat anemia：HIF-stabilizer BAY 85-3934(Molidustat)stimulates erythropoietin production without hypertensive effects [J]. PLoS One，2014，9(11)：e111838.
[36] Maxwell PH，Eckardt KU. HIF prolyl hydroxylase inhibitors for the treatment of renal anaemia and beyond [J]. Nat Rev Nephrol，2016，12(3)：157-168.
[37] Schmid H，Jelkmann W. Investigational therapies for renal disease-induced anemia [J]. Expert Opin Investig Drugs，2016，25(8)：901-916.
(收稿日期：2016-08-01 本文編辑：张瑜杰), 百拇医药(刘珊 丁国华 王惠明)
[33] Hara K，Takahashi N，Wakamatsu A，et al. Pharmacokinetics，pharmacodynamics and safety of single，oral doses of GSK1278863，a novel HIF-prolyl hydroxylase inhibitor，in healthy Japanese and Caucasian subjects [J]. Drug Metab Pharmacokinet，2015，30(6)：410-418.
[34] Brigandi RA，Johnson B，Oei C，et al. A Novel Hypoxia-Inducible Factor-Prolyl Hydroxylase Inhibitor(GSK12 78863)for Anemia in CKD：A 28-Day，Phase 2A Randomized Trial [J]. Am J Kidney Dis，2016，67(6)：861-871.
[35] Flamme I，Oehme F，Ellinghaus P，et al. Mimicking hypoxia to treat anemia：HIF-stabilizer BAY 85-3934(Molidustat)stimulates erythropoietin production without hypertensive effects [J]. PLoS One，2014，9(11)：e111838.
[36] Maxwell PH，Eckardt KU. HIF prolyl hydroxylase inhibitors for the treatment of renal anaemia and beyond [J]. Nat Rev Nephrol，2016，12(3)：157-168.
[37] Schmid H，Jelkmann W. Investigational therapies for renal disease-induced anemia [J]. Expert Opin Investig Drugs，2016，25(8)：901-916.
(收稿日期：2016-08-01 本文編辑：张瑜杰), 百拇医药(刘珊 丁国华 王惠明)